Cargando…

完全电视胸腔镜手术与胸腔镜辅助小切口手术治疗早期非小细胞肺癌临床疗效的Meta分析

BACKGROUND AND OBJECTIVE: The aim of this study is to assess the effect of video-assisted thoracoscopic surgery (VATS) and video-assisted mini-thoracotomy (VAMT) in the treatment of non-small cell lung cancer (NSCLC). METHODS: We searched PubMed, EMbase, CNKI, VIP and ISI Web of Science to collect r...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973069/
https://www.ncbi.nlm.nih.gov/pubmed/28532537
http://dx.doi.org/10.3779/j.issn.1009-3419.2017.05.02
_version_ 1783326545834672128
collection PubMed
description BACKGROUND AND OBJECTIVE: The aim of this study is to assess the effect of video-assisted thoracoscopic surgery (VATS) and video-assisted mini-thoracotomy (VAMT) in the treatment of non-small cell lung cancer (NSCLC). METHODS: We searched PubMed, EMbase, CNKI, VIP and ISI Web of Science to collect randomized controlled trials (RCTs) of VATS versus VAMT for NSCLC. Each database was searched from May 2006 to May 2016. Two reviewers independently assessed the quality of the included studies and extracted relevant data, using RevMan 5.3 meta-analysis software. RESULTS: We finally identified 13 RCTs involving 1, 605 patients. There were 815 patients in the VATS group and 790 patients in the VAMT group. The results of meta-analysis were as follows: statistically significant difference was found in the harvested lymph nodes (SMD=-0.48, 95%CI: -0.80--0.17), operating time (SMD=13.56, 95%CI: 4.96-22.16), operation bleeding volume (SMD=-33.68, 95%CI: -45.70--21.66), chest tube placement time (SMD=-1.05, 95%CI: -1.48--0.62), chest tube drainage flow (SMD=-83.69, 95%CI: -143.33--24.05), postoperative pain scores (SMD=-1.68, 95%CI: -1.98--1.38) and postoperative hospital stay (SMD=-2.27, 95%CI: -3.23--1.31). No statistically significant difference was found in postoperative complications (SMD=0.83, 95%CI: 0.54-1.29) and postoperative mortality (SMD=0.95, 95%CI: 0.55-1.63) between videoassisted thoracoscopic surgery lobectomy and video-assisted mini-thoracotomy lobectomy in the treatment of NSCLC. CONCLUSION: Compared with video-assisted mini-thoracotomy lobectomy in the treatment of non-small cell lung cancer, the amount of postoperative complications and postoperative mortality were almost the same in video-assisted thoracoscopic lobectomy, but the amount of harvested lymph nodes, operating time, blood loss, chest tube drainage flow, and postoperative hospital stay were different. VATS is safe and effective in the treatment of NSCLC.
format Online
Article
Text
id pubmed-5973069
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-59730692018-07-06 完全电视胸腔镜手术与胸腔镜辅助小切口手术治疗早期非小细胞肺癌临床疗效的Meta分析 Zhongguo Fei Ai Za Zhi 临床研究 BACKGROUND AND OBJECTIVE: The aim of this study is to assess the effect of video-assisted thoracoscopic surgery (VATS) and video-assisted mini-thoracotomy (VAMT) in the treatment of non-small cell lung cancer (NSCLC). METHODS: We searched PubMed, EMbase, CNKI, VIP and ISI Web of Science to collect randomized controlled trials (RCTs) of VATS versus VAMT for NSCLC. Each database was searched from May 2006 to May 2016. Two reviewers independently assessed the quality of the included studies and extracted relevant data, using RevMan 5.3 meta-analysis software. RESULTS: We finally identified 13 RCTs involving 1, 605 patients. There were 815 patients in the VATS group and 790 patients in the VAMT group. The results of meta-analysis were as follows: statistically significant difference was found in the harvested lymph nodes (SMD=-0.48, 95%CI: -0.80--0.17), operating time (SMD=13.56, 95%CI: 4.96-22.16), operation bleeding volume (SMD=-33.68, 95%CI: -45.70--21.66), chest tube placement time (SMD=-1.05, 95%CI: -1.48--0.62), chest tube drainage flow (SMD=-83.69, 95%CI: -143.33--24.05), postoperative pain scores (SMD=-1.68, 95%CI: -1.98--1.38) and postoperative hospital stay (SMD=-2.27, 95%CI: -3.23--1.31). No statistically significant difference was found in postoperative complications (SMD=0.83, 95%CI: 0.54-1.29) and postoperative mortality (SMD=0.95, 95%CI: 0.55-1.63) between videoassisted thoracoscopic surgery lobectomy and video-assisted mini-thoracotomy lobectomy in the treatment of NSCLC. CONCLUSION: Compared with video-assisted mini-thoracotomy lobectomy in the treatment of non-small cell lung cancer, the amount of postoperative complications and postoperative mortality were almost the same in video-assisted thoracoscopic lobectomy, but the amount of harvested lymph nodes, operating time, blood loss, chest tube drainage flow, and postoperative hospital stay were different. VATS is safe and effective in the treatment of NSCLC. 中国肺癌杂志编辑部 2017-05-20 /pmc/articles/PMC5973069/ /pubmed/28532537 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.05.02 Text en 版权所有©《中国肺癌杂志》编辑部2017 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 临床研究
完全电视胸腔镜手术与胸腔镜辅助小切口手术治疗早期非小细胞肺癌临床疗效的Meta分析
title 完全电视胸腔镜手术与胸腔镜辅助小切口手术治疗早期非小细胞肺癌临床疗效的Meta分析
title_full 完全电视胸腔镜手术与胸腔镜辅助小切口手术治疗早期非小细胞肺癌临床疗效的Meta分析
title_fullStr 完全电视胸腔镜手术与胸腔镜辅助小切口手术治疗早期非小细胞肺癌临床疗效的Meta分析
title_full_unstemmed 完全电视胸腔镜手术与胸腔镜辅助小切口手术治疗早期非小细胞肺癌临床疗效的Meta分析
title_short 完全电视胸腔镜手术与胸腔镜辅助小切口手术治疗早期非小细胞肺癌临床疗效的Meta分析
title_sort 完全电视胸腔镜手术与胸腔镜辅助小切口手术治疗早期非小细胞肺癌临床疗效的meta分析
topic 临床研究
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973069/
https://www.ncbi.nlm.nih.gov/pubmed/28532537
http://dx.doi.org/10.3779/j.issn.1009-3419.2017.05.02
work_keys_str_mv AT wánquándiànshìxiōngqiāngjìngshǒushùyǔxiōngqiāngjìngfǔzhùxiǎoqièkǒushǒushùzhìliáozǎoqīfēixiǎoxìbāofèiáilínchuángliáoxiàodemetafēnxī
AT wánquándiànshìxiōngqiāngjìngshǒushùyǔxiōngqiāngjìngfǔzhùxiǎoqièkǒushǒushùzhìliáozǎoqīfēixiǎoxìbāofèiáilínchuángliáoxiàodemetafēnxī
AT wánquándiànshìxiōngqiāngjìngshǒushùyǔxiōngqiāngjìngfǔzhùxiǎoqièkǒushǒushùzhìliáozǎoqīfēixiǎoxìbāofèiáilínchuángliáoxiàodemetafēnxī
AT wánquándiànshìxiōngqiāngjìngshǒushùyǔxiōngqiāngjìngfǔzhùxiǎoqièkǒushǒushùzhìliáozǎoqīfēixiǎoxìbāofèiáilínchuángliáoxiàodemetafēnxī
AT wánquándiànshìxiōngqiāngjìngshǒushùyǔxiōngqiāngjìngfǔzhùxiǎoqièkǒushǒushùzhìliáozǎoqīfēixiǎoxìbāofèiáilínchuángliáoxiàodemetafēnxī